Hepatocellular carcinoma (HCC) is one of the leading cancers worldwide. Classically, HCC
develops in genetically susceptible individuals who are exposed to risk factors, especially in …

Each Association appointed at least one author to serve on the writing group. The Chair of
the writing group was appointed by the AASLD. Members of the writing group were not …

Pediatric hepatocellular carcinoma (HCC) is the second common malignant liver tumor in
children after hepatoblastoma. It differs from the adult HCC in the etiological predisposition …

GSD‐I, III, and IV are congenital disorders of glycogen metabolism that are commonly
associated with severe liver disease. Liver transplantation has been proposed as a therapy …

OBJECTIVES: To establish risks for development of hepatocellular carcinoma (HCC) in
children with biliary atresia (BA), the most common chronic liver disease of childhood …

Introduction. Hepatocellular carcinoma (HCC) is a rare pediatric cancer accounting for 0.5%
of all pediatric malignancies. This study examines a large cohort of HCC patients in an effort …

Glycogen storage disease type I (GSDI), an inborn error of carbohydrate metabolism, is
caused by defects in the glucose-6-transporter/glucose-6-phosphatase complex, which is …

Adjusted survival outcomes following hepatic resection and transplantation for pediatric liver
tumors have not been compared. To address this question, we conducted a retrospective …

Glycogen storage disease type Ia (GSD-Ia) profoundly impairs glucose release by the liver
due to glucose-6-phosphatase (G6Pase) deficiency. An adeno-associated virus (AAV) …

The aim of this study was to collect data from patients who underwent liver transplantation
(LT) for adenomatosis; to analyze the symptoms, the characteristics of the disease, and the …